Completed PHASE2 INTERVENTIONAL NCT00215384
Study in Patients With COPD
Sponsor: Dey
Conditions
COPD
Interventions
Formoterol Fumarate
Updated 5 times since 2017 Last updated: Nov 10, 2010 Primary completion: Apr 30, 2003 Completion: Oct 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00215384, this PHASE2 trial focuses on COPD and remains completed. Sponsored by Dey, it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Dey
Data source: Dey
For direct contact, visit the study record on ClinicalTrials.gov .